Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-04-05

Clinical Trial Update: Double-blind Randomized Clinical Trial of Transcranial Magnetic Stimulation in Chronic Migraine [Phase 1]

View source ↗

Summary

Phase 1 double-blind randomized trial evaluating transcranial magnetic stimulation for chronic migraine has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Transcranial Magnetic Stimulation (TMS)

Snippet

Sponsor: Hospital Israelita Albert Einstein | Conditions: Chronic Migraine | Phase 1 | Status: COMPLETED